Issue Information

Issue Information
Published: (2025)

Issue Information
Published: (2025)

Issue Information
Published: (2025)

Issue Information
Published: (2026)

Issue Information
Published: (2026)

Issue Information
Published: (2026)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2026)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Issue Information
Published: (2024)

Dual Therapy Triumph: Yuquan Capsules and Metformin in Combating Type 2 Diabetes Mellitus Disorders
by: Lufan Zhang, et al.
Published: (2025)

Pharmacokinetics and bioequivalence of two N‐acetylcysteine tablets in healthy Chinese volunteers under fasting and fed conditions
by: Xianmiao Yin, et al.
Published: (2025)

A Phase 1, Randomized, Placebo‐Controlled, Multiple‐Dose, Double‐Blind Study to Evaluate and Compare the Pharmacokinetics and Safety of Rimegepant in Healthy Adult Japanese and Caucasian Individuals
by: Rajinder Bhardwaj, et al.
Published: (2025)

Evaluation of clinical cardiac safety of zilurgisertib, an activin receptor‐like kinase‐2 (ALK2) inhibitor, in healthy participants
by: Yan‐ou Yang, et al.
Published: (2025)

Disposition and Absolute Bioavailability of Orally Administered Orforglipron in Healthy Participants
by: Bridget L. Morse, et al.
Published: (2025)

Effect of Cytochrome P450 3A Inhibition and Induction by Itraconazole and Rifampin on Tazemetostat Pharmacokinetics in Patients With Advanced Malignancies
by: Yingxue Chen, et al.
Published: (2025)

Bioequivalence Study of 2 Formulations of Fluticasone Nasal Spray in Healthy Chinese Volunteers
by: Gang Chen, et al.
Published: (2025)

Safety, Tolerability, and Pharmacokinetics of Donanemab in Healthy Chinese Participants: A Phase 1, Randomized, Double‐Blind, Placebo‐Controlled Study
by: Junyu Xu, et al.
Published: (2025)

A Phase 1C, Open Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DM199 Administered Intravenously with a Polyvinyl Chloride Bag in Adult Healthy Subjects and Adults Recently Taking Angiotensin‐Converting Enzyme Inhibitors
by: Michael Giuffre, et al.
Published: (2025)

Pharmacokinetics and Safety Evaluation of a New Generic Sitafloxacin: A Phase I Bioequivalence Study in Healthy Chinese Participants
by: Yongfang Lei, et al.
Published: (2025)

First‐in‐Human Study of Merotocin, a Short‐Acting Peptidic Oxytocin Receptor Agonist for Lactation Support
by: Yu Bagger, et al.
Published: (2025)

Phase 1 Mass Balance Study of Pizuglanstat: An Investigational Hematopoietic Prostaglandin D Synthase Inhibitor
by: Ryuzo Hanada, et al.
Published: (2025)

Strategies to Manage Dosing Deviations and Interruptions of Cabotegravir Long‐Acting Intramuscular Injections
by: Kelong Han, et al.
Published: (2025)

Combined Immediate‐Release and Extended‐Release Formulation of Sodium Valproate Provides Stable Plasma Levels for Inhibition of Histone Deacetylation
by: Nikhil Ahuja, et al.
Published: (2025)

Extrapolation of Midazolam Disposition in Neonates Using Physiological‐Based Pharmacokinetic/Pharmacodynamic Modeling
by: Tangping Zhao, et al.
Published: (2025)

Impact of Sotorasib, a KRAS G12C Inhibitor, on the Pharmacokinetics and Therapeutic Window of Digoxin, a P‐Glycoprotein Substrate
by: Panli Cardona, et al.
Published: (2025)

Safety, Tolerability, and Pharmacokinetics of Galcanezumab, an Anti‐CGRP Antibody, in Healthy Chinese Participants
by: Jingjing Wang, et al.
Published: (2025)

A 2‐Part, Open‐Label, Phase 1 Bioequivalence and Food‐Effect Study of Ubrogepant in Healthy Adult Participants
by: Ramesh Boinpally, et al.
Published: (2025)

Pharmacokinetics, Bioequivalence, and Safety of Levothyroxine Sodium Tablets in Healthy Chinese Subjects
by: Juan Jin, et al.
Published: (2025)